EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $214,000 | -2.7% | 4,329 | 0.0% | 0.00% | – |
| Q4 2021 | $220,000 | -9.1% | 4,329 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $242,000 | +30.8% | 4,329 | 0.0% | 0.00% | – |
| Q2 2021 | $185,000 | +2.8% | 4,329 | 0.0% | 0.00% | – |
| Q1 2021 | $180,000 | -10.9% | 4,329 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $202,000 | +9.8% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $184,000 | -11.5% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $208,000 | +4.5% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $199,000 | -23.5% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $260,000 | -35.5% | 4,329 | -39.2% | 0.00% | 0.0% |
| Q3 2019 | $403,000 | +219.8% | 7,120 | +216.4% | 0.00% | – |
| Q2 2019 | $126,000 | +10.5% | 2,250 | 0.0% | 0.00% | – |
| Q1 2019 | $114,000 | +26.7% | 2,250 | 0.0% | 0.00% | – |
| Q4 2018 | $90,000 | -42.3% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $156,000 | – | 2,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |